Avidity Partners Management LP 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:26 pm Sale | 2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Avidity Partners Management LP | 2,040,000 4.100% | -2,365,000 (-53.69%) | Filing |
| 2022-02-11 7:52 pm Purchase | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Avidity Partners Management LP | 4,405,000 9.200% | 120,000 (+2.80%) | Filing |
| 2021-03-22 4:05 pm Purchase | 2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Avidity Partners Management LP | 4,285,000 9.400% | 4,285,000 (New Position) | Filing |